RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Lung Cancer

A collection of news and information related to Lung Cancer published by this site and its partners.

Top Lung Cancer Articles see all

Displaying items 1-5
  • Hartford HealthCare Launches Alliance With Leading NYC Cancer Center

    Hartford HealthCare Launches Alliance With Leading NYC Cancer Center
    HARTFORD — The alliance Hartford HealthCare announced a year ago with Memorial Sloan Kettering to tap into the leading New York cancer center's research and treatment capabilities is moving forward.
  • Joe Sample dies at 75; jazz-funk keyboardist founded the Crusaders

    Joe Sample dies at 75; jazz-funk keyboardist founded the Crusaders
    Joe Sample, a soft-spoken keyboard player and composer whose blending of funk, blues, jazz, gospel and the Zydeco music of his childhood lent a distinctive sound to his well-known group, the Crusaders, has died. He was 75. Sample died Friday at a...

    Spontaneous cancer remission rare, but worth study

    Spontaneous cancer remission rare, but worth study
    In her 28-year career, Dr. Deborah Axelrod says she's had just one patient whose advanced breast cancer inexplicably vanished. The patient, Ann Fonfa, endured multiple surgeries to remove cancerous tumors that kept growing back. All the while, Fonfa...

    Joe Sample dies at 75; influential jazz-funk pianist

    Influential keyboardist Joe Sample, who helped push the boundaries of jazz and funk as a member of the Jazz Crusaders, died Friday in Houston. He was 75. Sample's career with the Jazz Crusaders began as a hard bop group in Texas in the late '50s...

    Lilly stomach cancer drug prolongs life in colon cancer study

    (Reuters) - Eli Lilly and Co's LLY.N Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday. Based on favorable data from the Phase III study, Lilly said it would ask...